SHOCKING: Weight loss - You Need To See This

Hair Loss Was Just the Start? The Nail Truth

Hair shedding became one of the most talked-about cosmetic complaints linked with GLP-1 medicines. Now, researchers have found another change that is drawing attention: nail problems. A study presented at the 2026 European Academy of Dermatology and Venereology (EADV) Congress found that nail detachment was reported by 39% of GLP-1…

MyLifeXP · 2h ago

GLP-1 Users Reported Nail Detachment Four Times as Often as Nonusers in an Early International Dermatology Survey

GLP-1 users reported nail detachment four times as often as nonusers in an early EADV survey. See what the nail and hair data show and do not prove.

Medical Daily · 11h ago

Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss

Rhode Island Medicaid stopped covering Wegovy, Zepbound, Saxenda, and Foundayo for weight loss on Oct. 1, 2026. Diabetes coverage continues. Here is what members should know.

Medical Daily · Oct 3

Lancet Publishes Full Petrelintide Trial: About 10% Weight Loss, Nausea in 20% as Amylin Drug Enters Phase 3

Full Phase 2 results for petrelintide in The Lancet show about 10% weight loss and nausea in 20%. What the experimental amylin drug means for patients.

Medical Daily · Oct 1

New weight loss drug combination helps patients lose 54 pounds in less than a year

Combining Mounjaro and Elora helped patients to shed almost a quarter of their body weight on average

The Independent UK · Oct 1

Newsom Signs Law Barring Sales of Diet Pills and Weight-Loss Supplements to California Minors Without a Prescription

California's AB 2030 bars sales of diet pills and weight-loss or muscle-building supplements to minors without a prescription. What parents should know.

Medical Daily · Oct 1

Foundayo Pill Edged Higher-Dose Oral Semaglutide on Weight and A1C in Lilly's Indirect Type 2 Diabetes Analysis

Lilly's indirect analysis found Foundayo 17.2 mg edged oral semaglutide 25 mg on weight and A1C in type 2 diabetes, but the gaps were modest.

Medical Daily · Oct 1

Eli Lilly vs. Novo: The Hidden Battle Behind the Weight-Loss Platform Reshaping Industries

GLP-1 is a drug platform, not one product. Lilly leads; Novo slips; Pfizer, Amgen, Roche, and AbbVie chase, with pricing, generic and trial risks.

Barchart · Sep 30

What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise

A recent study found that creatine supplementation can increase lean muscle tissue in middle-aged adults. Participants aged 45 to 65 who took creatine gained muscle even without exercise. Those who incorporated exercise and a calorie-reduced diet showed even greater improvements in strength. Additionally, creatine helped preserve muscle during weight loss…

The Economic Times · Sep 30

Doctor Weighs In After Hollywood Veteran’s Dramatic Weight Loss Has Everyone Making The Same Observation

John Goodman’s dramatically slimmer appearance has sent fans into a frenzy, with many questioning whether weight-loss medication played a role in his astonishing transformation. An expert now explains what his appearance can and cannot reveal.

Bored Panda · Sep 30